阿亚洛雷和勒洛里耶就文章《非ST段抬高型急性冠状动脉综合征后非持续性室性心动过速与心源性猝死的关系：来自随机对照试验“雷诺嗪改善非ST段抬高型急性冠状动脉综合征心肌缺血的代谢效率-心肌梗死溶栓36（MERLIN-TIMI 36）”的观察结果》所写的信。 - Suppr | 超能文献

Letter by Ayalloore and LeLorier regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial".

作者信息

Ayalloore Siby G, LeLorier Paul

出版信息

Circulation. 2011 Apr 12;123(14):e404; author reply e405. doi: 10.1161/CIRCULATIONAHA.110.985093.

DOI:10.1161/CIRCULATIONAHA.110.985093

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Letter by Ayalloore and LeLorier regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial".阿亚洛雷和勒洛里耶就文章《非ST段抬高型急性冠状动脉综合征后非持续性室性心动过速与心源性猝死的关系：来自随机对照试验“雷诺嗪改善非ST段抬高型急性冠状动脉综合征心肌缺血的代谢效率-心肌梗死溶栓36（MERLIN-TIMI 36）”的观察结果》所写的信。

Circulation. 2011 Apr 12;123(14):e404; author reply e405. doi: 10.1161/CIRCULATIONAHA.110.985093.

2

Letter by Madias regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial".马迪亚斯就“非ST段抬高型急性冠脉综合征后非持续性室性心动过速与心源性猝死的关系：来自非ST段抬高型急性冠脉综合征中使用雷诺嗪提高代谢效率减少缺血——心肌梗死溶栓36（MERLIN-TIMI 36）随机对照试验的观察结果”一文所写的信函

Circulation. 2011 Apr 12;123(14):e403; author reply e405. doi: 10.1161/CIRCULATIONAHA.110.984674.

3

Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial.非 ST 段抬高型急性冠状动脉综合征后非持续性室性心动过速与心源性猝死的关系：来自瑞马唑仑减少非 ST 段抬高型急性冠状动脉综合征心肌梗死溶栓 36 试验（MERLIN-TIMI 36）随机对照研究的代谢效率观察。

Circulation. 2010 Aug 3;122(5):455-62. doi: 10.1161/CIRCULATIONAHA.110.937136. Epub 2010 Jul 19.

4

Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36).不稳定型缺血性心脏病女性患者的临床特征和结局：雷诺嗪改善非 ST 段抬高型急性冠脉综合征心肌梗死溶栓 36 试验（MERLIN-TIMI 36）中的代谢效率观察

Circulation. 2010 Apr 27;121(16):1809-17. doi: 10.1161/CIRCULATIONAHA.109.897231. Epub 2010 Apr 12.

5

Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.急性冠状动脉综合征后连续心电图检测到的缺血：来自MERLIN-TIMI 36（雷诺嗪改善非ST段抬高型急性冠状动脉综合征缺血的代谢效率-心肌梗死溶栓治疗36）试验的观察结果

J Am Coll Cardiol. 2009 Apr 21;53(16):1411-21. doi: 10.1016/j.jacc.2008.12.053.

6

Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.雷诺嗪提高非ST段抬高型急性冠脉综合征患者代谢效率以减少心肌缺血（MERLIN TIMI-36）研究

Expert Rev Cardiovasc Ther. 2008 Jan;6(1):9-16. doi: 10.1586/14779072.6.1.9.

7

Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome (from the MERLIN-TIMI 36 Trial).连续心电图监测的心肌缺血和室性心动过速与非 ST 段抬高型急性冠脉综合征（MERLIN-TIMI 36 试验）后心血管结局的风险。

Am J Cardiol. 2011 Nov 15;108(10):1373-81. doi: 10.1016/j.amjcard.2011.06.058. Epub 2011 Sep 3.

8

Relation of T-wave alternans to mortality and nonsustained ventricular tachycardia in patients with non-ST-segment elevation acute coronary syndrome from the MERLIN-TIMI 36 trial of ranolazine versus placebo.美西律胺对非 ST 段抬高型急性冠脉综合征患者死亡率和非持续性室性心动过速的影响——来自 MERLIN-TIMI 36 试验的研究

Am J Cardiol. 2014 Jul 1;114(1):17-23. doi: 10.1016/j.amjcard.2014.03.056. Epub 2014 Apr 16.

9

Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).多标志物在非 ST 段抬高型急性冠状动脉综合征患者中的预后表现：来自 MERLIN-TIMI 36 试验（雷诺嗪在非 ST 段抬高型急性冠状动脉综合征中的代谢效益降低缺血-心肌梗死溶栓 36）的分析。

J Am Coll Cardiol. 2014 Apr 29;63(16):1644-53. doi: 10.1016/j.jacc.2013.12.034. Epub 2014 Feb 13.

10

Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.新型抗缺血药物在急性冠状动脉综合征中的评估：非ST段抬高型急性冠状动脉综合征中雷诺嗪提高代谢效率减少缺血（MERLIN）-TIMI 36试验的设计与原理

Am Heart J. 2006 Jun;151(6):1186.e1-9. doi: 10.1016/j.ahj.2006.01.004.